Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
79,310,345
-
Total 13F shares
-
43,122,410
-
Share change
-
+8,992,075
-
Total reported value
-
$501,522,245
-
Put/Call ratio
-
98%
-
Price per share
-
$11.63
-
Number of holders
-
189
-
Value change
-
+$101,792,720
-
Number of buys
-
141
-
Number of sells
-
59
Institutional Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q3 2025
As of 30 Sep 2025,
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,122,410 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, MARSHALL WACE, LLP, DEERFIELD MANAGEMENT COMPANY, L.P., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Alyeska Investment Group, L.P., UBS Group AG, and MORGAN STANLEY.
This page lists
189
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.